Current Report Filing (8-k)
18 October 2018 - 6:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported):
October
17, 2018
IntelGenx Technologies
Corp.
(Exact name of registrant as specified in its charter)
Delaware
|
000-31187
|
87-0638336
|
(State or other jurisdiction
|
(Commission File No.)
|
(IRS Employer ID)
|
of incorporation)
|
|
|
6420 Abrams, Ville Saint Laurent, Quebec, H4S 1Y2 Canada
(Address of principal executive offices and Zip Code)
(514) 331-7440
(Registrant's telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2
of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. [ ]
Since September 15, 2018, IntelGenx Technologies Corp. (the
Company) received proceeds of $1,634,294 as a result of the exercise of
2,894,606 previously issued common stock purchase warrants (the Previous
Warrants).
The exercised Previous Warrants were issued in connection with
our public offering of units completed in December 2013, and were set to expire
on December 15, 2018. The exercise price of the Previous Warrants was $0.5646.
Following the exercise of the Previous Warrants, the Company continues to have
an aggregate of 2,730,371 common stock purchase warrants outstanding, of which
76,296 were issued under the December 2013 public offering and 2,654,075 were
issued under the Companys May 2018 private placement.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
INTELGENX TECHNOLOGIES CORP.
|
|
|
Dated: October 17, 2018
|
By:
/s/ Ingrid Zerbe
|
|
Ingrid Zerbe
|
|
Corporate Secretary
|
IntelGenx Technologies (QB) (USOTC:IGXT)
Historical Stock Chart
From Mar 2024 to May 2024
IntelGenx Technologies (QB) (USOTC:IGXT)
Historical Stock Chart
From May 2023 to May 2024